TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company whose core business model involves the development of novel cancer therapeutics. This process inherently requires extensive animal testing to satisfy regulatory requirements for safety and efficacy prior to human clinical trials. The company’s research and development activities are built upon preclinical studies using animal models, as evidenced by its scientific publications and partnerships.

While specific financials detailing the scale of animal usage are not publicly broken out, the company’s entire pipeline and value proposition are predicated on successful animal testing. TRACON is listed by Cruelty Free Investors among companies that exploit animals for commercial purposes. The use of animals is not incidental but a fundamental and unavoidable component of its business in developing and seeking approval for new pharmaceutical products.